• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Kita-kyushu lung cancer antigen 1 (CT83)

Amino acids 1-113 constitute the expression domain of recombinant Human CT83. This CT83 protein is expected to have a theoretical molecular weight of 26.8 kDa. This CT83 recombinant protein is manufactured in e.coli. Fusion of the N-terminal 6xHis-B2M tag into the CT83 encoding gene fragment was conducted, allowing for easier detection and purification of the CT83 protein in subsequent stages.Human kita-Kyushu lung cancer antigen 1 (CT83) is a cancer-testis antigen implicated in tumorigenesis. CT83 is overexpressed in various cancers, particularly lung cancer. Investigation of CT83 provides insights into cancer biology, immunotherapy targets, and potential applications in cancer prognostics, and therapeutic strategies. In cancer research, CT83 is a potential biomarker for prognosis. Its role in immune responses makes it relevant in immunotherapy research. Additionally, CT83's involvement in tumor cell proliferation and survival suggests its contribution to oncogenic processes.

ACP02436

Amino acids 1-113 constitute the expression domain of recombinant Human CT83. This CT83 protein is expected to have a theoretical molecular weight of 26.8 kDa. This CT83 recombinant protein is manufactured in e.coli. Fusion of the N-terminal 6xHis-B2M tag into the CT83 encoding gene fragment was conducted, allowing for easier detection and purification of the CT83 protein in subsequent stages.Human kita-Kyushu lung cancer antigen 1 (CT83) is a cancer-testis antigen implicated in tumorigenesis. CT83 is overexpressed in various cancers, particularly lung cancer. Investigation of CT83 provides insights into cancer biology, immunotherapy targets, and potential applications in cancer prognostics, and therapeutic strategies. In cancer research, CT83 is a potential biomarker for prognosis. Its role in immune responses makes it relevant in immunotherapy research. Additionally, CT83’s involvement in tumor cell proliferation and survival suggests its contribution to oncogenic processes.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02436 Target NameCT83
Target SynonymsCT83; CXorf61; KKLC1; Kita-kyushu lung cancer antigen 1; KK-LC-1; Cancer/testis antigen 83FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-113aa
Mol Weight26.8kDaProtein LengthFull length
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5H943
Background Information
  • Uniprot Id

    Q5H943

  • Target Species

    Human

  • Target Name

    CT83

  • Target Full Name

    Kita-kyushu lung cancer antigen 1

  • Target Subcellular Location

    Cell membrane; Single-pass type II membrane protein.

  • Target Tissue Specificity

    Specifically expressed in testis. Expressed by cancer cell lines.

  • Target Research Area

    Cancer

  • Target Synonyms

    CT83; CXorf61; KKLC1; Kita-kyushu lung cancer antigen 1; KK-LC-1; Cancer/testis antigen 83

Inquire Recombinant Human Kita-kyushu lung cancer antigen 1 (CT83) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification